Laekna (HKSE:02105) ROCE %: -20.64% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02105 Laekna Inc HKSE:02105
30 GF Score
Price HK$6.05
! 2 Warning Signs
View Full Analysis

What is Laekna ROCE %?

Laekna HKSE:02105 -6.27% 30 ROCE % is -20.64% as of Dec. 2025. GuruFocus rates HKSE:02105 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Laekna's annualized ROCE % for the quarter that ended in Dec. 2025 was -20.64%.

Laekna  (HKSE:02105) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Laekna ROCE % Related Terms

Laekna ROCE % Historical Data

* Premium members only.

The historical data trend for Laekna's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laekna ROCE % Chart

Laekna Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
-179.45 -185.89 -61.03 -30.57 -22.89

Laekna Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only -33.83 -37.73 -29.01 -33.77 -20.64
HKSE:02105
30GF Score
Laekna Inc HKSE:02105
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laekna ROCE % Calculation

Laekna's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-249.054/( ( (1025.005 - 158.52) + (1562.994 - 253.625) )/ 2 )
=-249.054/( (866.485+1309.369)/ 2 )
=-249.054/1087.927
=-22.89 %

Laekna's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-216.17/( ( (998.411 - 212.824) + (1562.994 - 253.625) )/ 2 )
=-216.17/( ( 785.587 + 1309.369 )/ 2 )
=-216.17/1047.478
=-20.64 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -20.64% mean?
Laekna (HKSE:02105) has a ROCE % of -20.64% as of Dec. 2025.
Is Laekna's ROCE % too high?
Laekna's current ROCE % is -20.64%. Overall, Laekna has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Laekna's ROCE % compare to VRTX and REGN?
Laekna's ROCE % of -20.64% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Laekna's current ROCE % is -20.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laekna stock overvalued right now?
Laekna (HKSE:02105) has a current ROCE % of -20.64%. The current ROCE % is -20.64%. Laekna's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Laekna (HKSE:02105), the current ROCE % is -20.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Laekna Business Description

Other Exchanges 4U4:Germany
Address No. 3-2-467, 5 Xingbin Road (Lin Li Center, Sino-Italy Ningbo Ecological Park, Zhejiang Province, Yuyao, CHN, 201203
Laekna Inc is a science-driven, clinical-stage biotechnology company. The company has established a comprehensive R&D infrastructure to accelerate the development of molecules from discovery to registrational trials. It has initiated seven clinical trials for LAE102, LAE103, LAE002 (afuresertib), LAE001 and LAE005 to address unmet medical needs in obesity and cancers. Laekna has two Core Products and other pipeline product candidates. Core Product LAE002 is an adenosine triphosphate (ATP) competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, breast cancer.
30GF Score

Get the complete analysis for HKSE:02105

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.05
Price